Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
INMB holding history
Inmune Bio, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INMB overviewAll 13F holders of INMBFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −60,000−100.0% | Sold out | Holders |
| Q4 2023 | 60,000 | $675.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 60,000 | $406.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 60,000 | $544.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 60,000 | $387.6K | <0.1% | +60,000 | New | Holders |